Track M1 Kliniken AG — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

M1 Kliniken AG M12.DE Open M1 Kliniken AG in new tab

15.18 EUR
P/E
15.18
EPS
0.95
Yield
3.29%
Safety Score
87
P/B
2.27
ROE
13.95
Beta
0.93
Loading chart...
Key Metrics
Earnings dateMay 19, 2026
P/E15.18
EPS0.95
Book Value6.36
Price to Book2.27
Debt/Equity12.74
Growth
Revenue Growth0.09%
Earnings Growth0.19%
Estimates
Forward P/E12.88
Forward EPS1.12
Dividend
Dividend Yield3.29%
Annual dividends0.50 EUR
Ex-Div. DateJuly 17, 2025
Payout52.48%

DCF Valuation

Tweak assumptions to recompute fair value for M1 Kliniken AG (M12.DE)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

M1 Kliniken AG Logo M1 Kliniken AG Analysis (M12.DE)

Germany Health Care Official Website Stock

Is M1 Kliniken AG a good investment? M1 Kliniken AG (M12.DE) is currently trading at 15.18 EUR.

In terms of valuation, the stock trades at a P/E ratio of 15.18. This valuation is generally in line with the broader market.

Earnings Schedule: M1 Kliniken AG is expected to release its next earnings report on May 19, 2026. The market consensus estimate for Forward EPS is 1.12.

For income investors, M1 Kliniken AG pays a dividend yield of 3.29%. With a payout ratio of 52%, the dividend appears sustainable.

Investor FAQ

Does M1 Kliniken AG pay a dividend?

Yes, it pays an annual dividend of 0.50 EUR (3.29% yield).

What asset class is M1 Kliniken AG?

M1 Kliniken AG is classified as a Stock. You can compare it against 9 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 19, 2026. The company currently has a trailing EPS of 0.95.

Company Profile

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

Exchange Ticker
GER (Germany) M12.DE
BER (Germany) M12.BE
DUS (Germany) M12.DU
FRA (Germany) M12.F
HAN (Germany) M12.HA
HAM (Germany) M12.HM
MUN (Germany) M12.MU
STU (Germany) M12.SG
PNK (United States) MKLNF
Dividend Yield

3.29%

Annual Dividends

0.50 EUR

Next ex. div date

July 17, 2025

Payout Ratio

52.48%

Historical Dividends
Year Total Dividends
2026 0.50 EUR
2025 0.50 EUR
2024 0.50 EUR
2019 0.30 EUR
2018 0.30 EUR
2017 0.30 EUR
2016 0.30 EUR

Yearly aggregated dividends

Dividends

M1 Kliniken AG
Jul 21, 2025 Paid
Dividend
0.5 EUR

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion